We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+11.6%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$169M
AUM Growth
-$76.8M
Cap. Flow
-$93.2M
Cap. Flow %
-55.03%
Top 10 Hldgs %
46.89%
Holding
105
New
8
Increased
16
Reduced
63
Closed
15

Top Buys

Rank Stock Value
1
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$1.53M
2
LEGN icon
Legend Biotech
LEGN
+$1.34M
3
ZLAB icon
Zai Lab
ZLAB
+$1.34M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$1.18M
5
BPMC
Blueprint Medicines
BPMC
+$1.1M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$11.2M
2
UNH icon
UnitedHealth
UNH
+$7.66M
3
MRK icon
Merck
MRK
+$7.43M
4
ABBV icon
AbbVie
ABBV
+$5.44M
5
ABT icon
Abbott
ABT
+$5.14M

Sector Composition

Rank Sector Weight
1 Healthcare 99.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LENZ
1
LENZ Therapeutics
LENZ
$158M
$23.2M 13.7%
977,245
-107,159
-10% -$2.38M
CTNM
2
Contineum Therapeutics
CTNM
$513M
$15.3M 9.05%
800,887
– –
LLY icon
3
Eli Lilly
LLY
$1.04T
$9.74M 5.75%
10,996
-12,419
-53% -$11.2M
UNH icon
4
UnitedHealth
UNH
$384B
$7.67M 4.53%
13,125
-13,550
-51% -$7.66M
GILD icon
5
Gilead Sciences
GILD
$166B
$5.12M 3.02%
61,065
-7,760
-11% -$592K
JNJ icon
6
Johnson & Johnson
JNJ
$603B
$4.2M 2.48%
25,900
-30,950
-54% -$4.93M
MLYS icon
7
Mineralys Therapeutics
MLYS
$2.37B
$3.99M 2.36%
329,513
-109,235
-25% -$1.32M
REGN icon
8
Regeneron Pharmaceuticals
REGN
$71.4B
$3.57M 2.11%
3,400
-2,640
-44% -$2.94M
PFE icon
9
Pfizer
PFE
$142B
$3.32M 1.96%
114,650
-66,750
-37% -$1.95M
TMO icon
10
Thermo Fisher Scientific
TMO
$197B
$3.25M 1.92%
5,250
-5,265
-50% -$3.12M
ABBV icon
11
AbbVie
ABBV
$448B
$3.12M 1.84%
15,800
-29,150
-65% -$5.44M
BSX icon
12
Boston Scientific
BSX
$65.6B
$2.77M 1.63%
33,026
-38,450
-54% -$3.03M
MRK icon
13
Merck
MRK
$310B
$2.73M 1.61%
24,000
-62,500
-72% -$7.43M
SYK icon
14
Stryker
SYK
$123B
$2.69M 1.59%
7,450
-5,400
-42% -$1.86M
ALNY icon
15
Alnylam Pharmaceuticals
ALNY
$36.4B
$2.67M 1.57%
9,690
-2,790
-22% -$726K
MDT icon
16
Medtronic
MDT
$107B
$2.64M 1.56%
29,350
-30,201
-51% -$2.54M
BMRN icon
17
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.59M 1.53%
36,870
-4,390
-11% -$367K
BMY icon
18
Bristol-Myers Squibb
BMY
$124B
$2.59M 1.53%
50,000
+20,000
+67% +$938K
AZN icon
19
AstraZeneca
AZN
$257B
$2.47M 1.46%
10,670
-155
-1% -$25K
BOLD
20
Boundless Bio
BOLD
$55.7M
$2.35M 1.39%
678,574
-3,700
-0.5% -$13.4K
AMGN icon
21
Amgen
AMGN
$198B
$2.28M 1.35%
7,090
-7,610
-52% -$2.49M
VRTX icon
22
Vertex Pharmaceuticals
VRTX
$123B
$2.25M 1.33%
4,840
-3,810
-44% -$1.83M
ABT icon
23
Abbott
ABT
$178B
$2.21M 1.31%
19,398
-46,850
-71% -$5.14M
ARGX icon
24
argenx
ARGX
$53.9B
$2.17M 1.28%
3,997
-2,525
-39% -$1.28M
IQV icon
25
IQVIA
IQV
$34.3B
$1.8M 1.06%
7,600
-8,000
-51% -$1.89M
1
2 3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
FWA
Fulcrum Wealth Advisors Bellevue, Washington $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM

Sectoral Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Sectoral Asset Management held 105 positions worth $169M, down 31% from $246M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sectoral Asset Management withdrew a net $93.2M in Q3 2024, closing 15 positions and reducing 63 holdings. Its most notable exit was Elevance Health, an estimated $2.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in iShares 0-3 Month Treasury Bond ETF worth $1.53M.

  • Sectoral Asset Management's largest Q3 2024 buy was iShares 0-3 Month Treasury Bond ETF: 15,200 shares worth $1.53M.
  • Sectoral Asset Management added most to Legend Biotech in Q3 2024, an estimated $1.34M increase.
  • Sectoral Asset Management's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $11.2M.
  • Sectoral Asset Management fully exited Elevance Health in Q3 2024, selling an estimated $2.44M.
  • Sectoral Asset Management's ten largest holdings make up 47% of its $169M portfolio in Q3 2024.
  • Sectoral Asset Management opened 8 new positions and closed 15 in Q3 2024.
  • Sectoral Asset Management's portfolio value fell 31% quarter-over-quarter to $169M.

Based on Sectoral Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.